lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

C103H105B3Br2LiN25O21S3 — CID 158584563

IUPAClithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
SMILESCC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CCOC(=O)c1nc(C)c(-c2ccc3ncc(C(=O)Nc4cc(-c5noc(C)n5)ccc4C)n3c2)s1.CCOC(=O)c1nc(C)c(Br)s1.Cc1nc(-c2ccc(C)c(NC(=O)c3cnc4ccc(-c5sc(C(=O)O)nc5C)cn34)c2)no1.Cc1nc(-c2ccc(C)c(NC(=O)c3cnc4ccc(B(O)O)cn34)c2)no1.Cc1nc(-c2ccc(C)c(NC(=O)c3cnc4ccc(Br)cn34)c2)no1.N[N-]O.[Li+]
InChIInChI=1S/C25H22N6O4S.C23H18N6O4S.C18H16BN5O4.C18H14BrN5O2.C12H24B2O4.C7H8BrNO2S.Li.H3N2O/c1-5-34-25(33)24-27-14(3)21(36-24)17-8-9-20-26-11-19(31(20)12-17)23(32)29-18-10-16(7-6-13(18)2)22-28-15(4)35-30-22;1-11-4-5-14(20-26-13(3)33-28-20)8-16(11)27-21(30)17-9-24-18-7-6-15(10-29(17)18)19-12(2)25-22(34-19)23(31)32;1-10-3-4-12(17-21-11(2)28-23-17)7-14(10)22-18(25)15-8-20-16-6-5-13(19(26)27)9-24(15)16;1-10-3-4-12(17-21-11(2)26-23-17)7-14(10)22-18(25)15-8-20-16-6-5-13(19)9-24(15)16;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-3-11-7(10)6-9-4(2)5(8)12-6;;1-2-3/h6-12H,5H2,1-4H3,(H,29,32);4-10H,1-3H3,(H,27,30)(H,31,32);3-9,26-27H,1-2H3,(H,22,25);3-9H,1-2H3,(H,22,25);1-8H3;3H2,1-2H3;;3H,1H2/q;;;;;;+1;-1
InChIKeyHTQZHPRONHXTPX-UHFFFAOYSA-N
MW2324.51 g/mol
LogP15.46
Rot. Bonds21

About lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (PubChem CID 158584563) has the molecular formula C103H105B3Br2LiN25O21S3 and a molecular weight of 2324.51 g/mol. Its IUPAC name is lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.

Molecular Properties

Compound Namelithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
PubChem CID158584563
Molecular FormulaC103H105B3Br2LiN25O21S3
Molecular Weight2324.51 g/mol
Exact Mass2321.59
IUPAC Namelithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
SMILESCC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CCOC(=O)c1nc(C)c(-c2ccc3ncc(C(=O)Nc4cc(-c5noc(C)n5)ccc4C)n3c2)s1.CCOC(=O)c1nc(C)c(Br)s1.Cc1nc(-c2ccc(C)c(NC(=O)c3cnc4ccc(-c5sc(C(=O)O)nc5C)cn34)c2)no1.Cc1nc(-c2ccc(C)c(NC(=O)c3cnc4ccc(B(O)O)cn34)c2)no1.Cc1nc(-c2ccc(C)c(NC(=O)c3cnc4ccc(Br)cn34)c2)no1.N[N-]O.[Li+]
InChIInChI=1S/C25H22N6O4S.C23H18N6O4S.C18H16BN5O4.C18H14BrN5O2.C12H24B2O4.C7H8BrNO2S.Li.H3N2O/c1-5-34-25(33)24-27-14(3)21(36-24)17-8-9-20-26-11-19(31(20)12-17)23(32)29-18-10-16(7-6-13(18)2)22-28-15(4)35-30-22;1-11-4-5-14(20-26-13(3)33-28-20)8-16(11)27-21(30)17-9-24-18-7-6-15(10-29(17)18)19-12(2)25-22(34-19)23(31)32;1-10-3-4-12(17-21-11(2)28-23-17)7-14(10)22-18(25)15-8-20-16-6-5-13(19(26)27)9-24(15)16;1-10-3-4-12(17-21-11(2)26-23-17)7-14(10)22-18(25)15-8-20-16-6-5-13(19)9-24(15)16;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-3-11-7(10)6-9-4(2)5(8)12-6;;1-2-3/h6-12H,5H2,1-4H3,(H,29,32);4-10H,1-3H3,(H,27,30)(H,31,32);3-9,26-27H,1-2H3,(H,22,25);3-9H,1-2H3,(H,22,25);1-8H3;3H2,1-2H3;;3H,1H2/q;;;;;;+1;-1
InChIKeyHTQZHPRONHXTPX-UHFFFAOYSA-N
XLogP15.46
TPSA607.58 Ų
H-Bond Donors9
H-Bond Acceptors43
Rotatable Bonds21
Heavy Atoms158
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002324.51
LogP ≤ 515.46
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The IUPAC name of lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (CID 158584563) is lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.
What is the SMILES notation for lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The canonical SMILES for lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CCOC(=O)c1nc(C)c(-c2ccc3ncc(C(=O)Nc4cc(-c5noc(C)n5)ccc4C)n3c2)s1.CCOC(=O)c1nc(C)c(Br)s1.Cc1nc(-c2ccc(C)c(NC(=O)c3cnc4ccc(-c5sc(C(=O)O)nc5C)cn34)c2)no1.Cc1nc(-c2ccc(C)c(NC(=O)c3cnc4ccc(B(O)O)cn34)c2)no1.Cc1nc(-c2ccc(C)c(NC(=O)c3cnc4ccc(Br)cn34)c2)no1.N[N-]O.[Li+].
What is the InChIKey of lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The InChIKey is HTQZHPRONHXTPX-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H22N6O4S.C23H18N6O4S.C18H16BN5O4.C18H14BrN5O2.C12H24B2O4.C7H8BrNO2S.Li.H3N2O/c1-5-34-25(33)24-27-14(3)21(36-24)17-8-9-20-26-11-19(31(20)12-17)23(32)29-18-10-16(7-6-13(18)2)22-28-15(4)35-30-22;1-11-4-5-14(20-26-13(3)33-28-20)8-16(11)27-21(30)17-9-24-18-7-6-15(10-29(17)18)19-12(2)25-22(34-19)23(31)32;1-10-3-4-12(17-21-11(2)28-23-17)7-14(10)22-18(25)15-8-20-16-6-5-13(19(26)27)9-24(15)16;1-10-3-4-12(17-21-11(2)26-23-17)7-14(10)22-18(25)15-8-20-16-6-5-13(19)9-24(15)16;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-3-11-7(10)6-9-4(2)5(8)12-6;;1-2-3/h6-12H,5H2,1-4H3,(H,29,32);4-10H,1-3H3,(H,27,30)(H,31,32);3-9,26-27H,1-2H3,(H,22,25);3-9H,1-2H3,(H,22,25);1-8H3;3H2,1-2H3;;3H,1H2/q;;;;;;+1;-1.
What are the key properties of lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane has a molecular weight of 2324.51 g/mol, XLogP of 15.46, 21 rotatable bonds, 9 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for lithium;amino(hydroxy)azanide;6-bromo-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide;ethyl 5-bromo-4-methyl-1,3-thiazole-2-carboxylate;ethyl 4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylate;4-methyl-5-[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole-2-carboxylic acid;[3-[[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]imidazo[1,2-a]pyridin-6-yl]boronic acid;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is sourced from PubChem (CID 158584563), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).